Exposure to this product may cause temporary or medically reversible adverse health consequences, according to the FDA.

The Food and Drug Administration’s top drug regulator, Dr. Tracy Beth Hoeg, is working to hire a researcher and friend who ...

Weight-loss patients may soon have access to more GLP-1 treatments as Eli Lilly confirmed the local regulator was evaluating its new oral obesity drug, orforglipron, which a recent study showed was ...

March 4 () - PepGen said on Wednesday that the U. Food and Drug Administration has placed ‌a partial clinical hold on its mid‑stage trial of ‌a rare muscle disease drug, sending its shares plunging ...

The FDA’s effort to crack down on compounded versions of popular GLP-1 weight-loss drugs has sparked backlash from patients and compounding pharmacies over concerns about access and ...

The FDA has outlined a proposed approval pathway for customized drugs and gene-editing therapies designed for rare and ...

A recent US Government-led testing programme has sparked concern among parents and consumers after arsenic — a toxic heavy ...

A new Environmental Working Group report says companies used a regulatory loophole known as “generally recognized as safe” to ...

Savannah Chrisley is facing scrutiny from federal regulators over the wording on her prescription weight loss website. The 28-year-old reality star received a warning letter from the Food and Drug ...

Chicken dog treats sold in five states are being recalled because the bags may be contaminated with Salmonella. The U.S. Food ...

This marks the facility’s second inspection by the FDA, after a March 2023 audit that also ended with zero observations.

Durham-based BioCryst Pharmaceuticals Inc. is advancing care for children living with hereditary angioedema (HAE) as it ...